41 episodes

Health Tech is a GeekWire podcast that explores the cutting edge of digital health. On each episode, we bring you stories about innovative technologies for patients, doctors and more, giving you a window into the future of health. Our third season is sponsored by Premera Blue Cross. Learn more about Premera here: http://bit.ly/2rSK8mT

GeekWire Health Tech GeekWire

    • Technology
    • 4.9, 25 Ratings

Health Tech is a GeekWire podcast that explores the cutting edge of digital health. On each episode, we bring you stories about innovative technologies for patients, doctors and more, giving you a window into the future of health. Our third season is sponsored by Premera Blue Cross. Learn more about Premera here: http://bit.ly/2rSK8mT

    Inside the boom in remote patient monitoring

    Inside the boom in remote patient monitoring

    The last time we caught up with Pillsy co-founders Jeff LeBrun and Chuks Onwuneme, three years ago, they were focused on their flagship product, a smart pill bottle that sounds an alarm if people forget to take their pills.

    But that was just one example of the broader trend of remote patient monitoring -- technology that helps medical professionals keep tabs on the status of patients at home, day in and day out, not just during periodic visits to the doctor’s office. Even before COVID-19 led to a boom in telehealth, LeBrun says, the need for better remote patient monitoring was becoming clear to Medicare officials, due to an aging population and a limited supply of health care workers.

    "There's been over a decade of research showing that remote patient monitoring has led to improved health outcomes and reduced costs," LeBrun says. "With a system that's already stretched thin, they knew that they needed to use more technology to try to handle this coming load of care that they would need to provide over the next 10 years. And so I think we're really just at the tip of the iceberg. Certainly what we're seeing now is accelerating that approach."

    • 20 min
    Webinar with Fred Hutch president - Special Invite

    Webinar with Fred Hutch president - Special Invite

    GeekWire Health Tech Podcast subscriber, you're invited to join us at 1:30 p.m. Pacific this Thursday, May 21, for a live online discussion with Dr. Thomas Lynch, the new president of the Fred Hutchinson Cancer Research Center. You may have caught my earlier conversation with Dr. Lynch on this podcast when he was just starting in the job, back in February. Of course, a lot has happened since then!

    Register for the webinar here.

    Scientists from the Seattle-based institute have emerged as leaders in the global effort to understand, track and reduce the spread of COVID-19. We’ll talk with Dr. Lynch about those initiatives, as well as Fred Hutch’s core cancer research efforts, and get an update on his long-term vision for Fred Hutch as an institution.

    Participation in these live webinars is normally exclusive to GeekWire members, but as a health tech podcast subscriber, you’re invited to join us for this one as our guest, and sample one of the perks of membership to see if you’d like to join. 

    Go here to register and submit a question, and join us online this Thursday 

    • 1 min
    The quest for a better COVID-19 test

    The quest for a better COVID-19 test

    In the world of diagnostic tests for COVID-19, there are two main approaches: PCR tests, which detect the presence of the live virus; and serology tests, which detect antibodies that indicate whether someone has recovered from the disease.

    But could there be a third way? Two companies based in the Seattle region, Microsoft and Adaptive Biotechnologies, are working together to try to create a better diagnostic test. Joining us to explain the initiative are Peter Lee, Microsoft corporate vice president of AI and Research, and Adaptive CEO Chad Robins. 

    At a basic level, Microsoft and Adaptive are looking for the unique signature associated with COVID-19 in the specialized cells that determine the human immune system's response to the disease. Once that signature is identified, they say, it could lead to a new test that would detect the tell-tale signs of the disease in others, providing a new form of diagnosis.

    The companies last week launched a virtual clinical study, seeking 1,000 people across the country who have been diagnosed with, exposed to, or recovered from COVID-19. The study is called “ImmuneRACE,” for Immune Response Action to COVID-19 Events. It focuses on 20 major metro regions in the US.. As of earlier this week, the study had more than 100 participants out of the 1,000 it’s seeking.

    • 24 min
    Psychedelics and the Future of Health

    Psychedelics and the Future of Health

    We’re exploring the intersection of psychedelics, health care, mental health and even spirituality with a journalist who has been reporting on the topic for GeekWire, two entrepreneurs looking to capitalize on future legalization of psychedelics, and a physician scientist who uses a form of psychedelics as part of his practice of medicine and psychotherapy.

    Related stories
    COVID-19 mental health crunch puts impetus on psychedelic drug innovation, doctor says
    Oregon psychedelic startup tests nasal spray for PTSD, depression as legislative momentum builds

    With Oregon activists pushing for state-wide decriminalization of magic mushrooms for therapeutic use this year, one local startup wants to keep the momentum going. Silo Wellness, based in Springfield, Oregon, has developed a nasal spray for microdosing psilocybin meant to aid with anxiety, PTSD and depression. The company now hopes to spread the good word, offering seminars for volunteers who normally wouldn't try it on the black market to test the device in a controlled setting in Jamaica, where magic mushrooms are legal.

    Joining us for this discussion Mike Arnold, founder of Silo Wellness; entrepreneur and consultant Eric Boone of Cannabinovation.com; Dr. Sunil Aggarwal, an affiliate clinical assistant professor at the University of Washington School of Medicine; and journalist Anastasia Ustinova.

    As the deadly coronavirus pandemic continues to grow, the looming mental health crisis creates an urgent need for innovation, putting a spotlight on psychedelic-assisted treatments, says Aggarwal, the co-founder of Advanced Integrative Medical Science Institute (AIMS) in Seattle.

    • 30 min
    An Objective Test for Autism?

    An Objective Test for Autism?

    SPOKANE, Wash. — If you showed up at an emergency room with a heart attack, you’d expect to receive some diagnostic tests like pulse, blood pressure and an EKG. You’d be surprised if medical professionals based their assessment only on how you looked, or how they perceived your behavior that day.

    Yet, that is exactly how autism spectrum disorder is diagnosed. Dr. Georgina Lynch, an assistant professor at Washington State University in Spokane, Wash., says autism is assessed with too limited a set of tools, focusing only on sociability and behavior markers that can often be perceived subjectively by healthcare providers.

    She started Appiture Biotechnologies to bring a new objective autism test to the healthcare market. Researchers have long hoped that a genetic marker or blood test would offer an objective clue to diagnosing autism. Instead, Dr. Lynch’s approach is based on what she finds to be a unique reaction to light in the pupils of people on the autism spectrum.

    “When we think of autism as just a behavioral or mental health disorder, that's the first mistake,” she said. “We need to think about it as a biological condition.”

    Read more and see a video of the test at geekwire.com/healthtech.

    This week's episode was reported, hosted and produced for GeekWire by Meredith Hogan, an independent multimedia journalist who produces documentary podcasts, video, films and interactive features. She worked previously for NBCNews.com and has a BS in Journalism from Northwestern University. Follow her @mer_hogan.

    • 22 min
    COVID-19 and the future of health tech

    COVID-19 and the future of health tech

    Much of the current focus in health care is rightly on the near-term challenges of the COVID-19 pandemic. But beyond the current crisis, health care technology veterans are already seeing major changes that promise to become permanent realities -- from the sudden boom in telemedicine, to regulatory shifts impacting health care billing, to the use of location data to track the disease.

    "Most interesting is what's going to happen when this is over," says Anne Weiler, the co-founder and former CEO of Seattle health tech startup Wellpepper, recently acquired by Caravan Health. "I don't think people are going to be satisfied with going back to the status quo, because these other things are now working."

    "I think these regulatory changes represent a big shift in how health care will be delivered beyond 2020," adds Nirav Shah, CEO of Sentinel Healthcare, a neurologist and the former stroke director at Swedish Hospital in Seattle. Sentinel recently launched a real-time fever tracking app for COVID-19 cases, and today announced that UT Health Austin will roll out its quarantine management program.

    But it will be key to deliver solutions that actually work for front-line health care workers, says Doug Cusick, CEO of Seattle startup TransformativeMed, which is offering its electronic record keeping application to screen COVID-19 patients, monitor symptom checklists, and track lab results and other data.

    "Look to technology to solve problems, but don't forget about these poor clinicians who've been left out in the process," Cusick explains. "The view has to be into solving these big communication and collaboration problems, which will enable so much else to work across our ecosystem."

    We introduced these health tech leaders recently and brought them together for a conversation about the COVID-19 crisis. The conversation quickly turned to the long-term implications for hospitals, clinicians, startups, patients and health technology.

    As a bonus, here are some of Anne Weiler's recommended Twitter accounts to follow, which she alluded to during the show.

    • 34 min

Customer Reviews

4.9 out of 5
25 Ratings

25 Ratings

Ahoog69 ,

Optimistically Eye Opening

Well produced and very fascinating. I just wish the episodes would come more frequently!

luvfromabuv ,

Great Podcast

I just started listening today and already impressed. Very simple explanations for complicated topics (i.e., healthcare system, CAT-S, etc). Good for folks who are new to these topics and just want basic understanding. The host is great at keeping it simple.

Jay Gerhart ,

Excellent podcast for disruption in healthcare

Very impressed with this podcast, well done! I strongly recommend this for healthcare leaders. Really enjoyed the episodes with Aaron Martin and Mark Long in particular - former Amazon leaders bringing an exciting perspective to healthcare. Providence St. Joseph Health is a very progressive healthcare system, with a strong mission - Look forward to hearing more from them.

Top Podcasts In Technology

Listeners Also Subscribed To